Endocrine Pathology

, Volume 17, Issue 2, pp 201–202 | Cite as

Genetic analysis of high altitude paragangliomas

  • Marion Jech
  • I. Alvarado-Cabrero
  • J. Albores-Saavedra
  • P. L. M. Dahia
  • A. S. Tischler
Letter

Keywords

Carotid Body Paraganglioma Carotid Body Tumor SDHD Mutation High Altitude Hypoxia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol 4:251–263, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Nathanson SD, Gaylis H. Multicentric chemodectomata at high altitude. A case report and review of the literature. S Afr Med J 48:1715–1717, 1974.PubMedGoogle Scholar
  3. 3.
    Arias-Stella J, Bustos F. Chronic hypoxia and chemodectomas in bovines at high altitudes. Arch Pathol Lab Med 100:636–639, 1976.PubMedGoogle Scholar
  4. 4.
    Pacheco-Ojeda L, Durango E, Rodriquez C, Vivar N. Carotid body tumors at high altitudes: Quito, Ecuador, 1987 World J Surg 12:856–860, 1988.PubMedCrossRefGoogle Scholar
  5. 5.
    Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck 20:374–378, 1998.PubMedCrossRefGoogle Scholar
  6. 6.
    Baysal BE. Genomic imprinting and environment in hereditary paraganglioma. Am J Med Genet C Semin Med Genet 129:85–90, 2004.PubMedCrossRefGoogle Scholar
  7. 7.
    Eisenhofer G, Bornstein SR, Brouwers FM, et al. Malignant pheochromocytoma: current status and initiatives for future progress. Endocr Relat Cancer 11:423–436, 2004.PubMedCrossRefGoogle Scholar
  8. 8.
    Schiavi F, Boedeker CC, Bausch B, et al. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057–2063, 2005.PubMedCrossRefGoogle Scholar
  9. 9.
    Aguiar RC, Cox G, Pomeroy SL, Dahia PL. Analysis of the SDHD gene, the susceptibility gene for familial paraganglioma syndrome (PGL1), in pheochromocytomas. J Clin Endocrinol Metab 86:2890–2894, 2001.PubMedCrossRefGoogle Scholar
  10. 10.
    Dahia PL, Ross KN, Wright ME, et al. A HIF1-alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1:e8, 2005.CrossRefGoogle Scholar
  11. 11.
    mcWhinney SR, Pilarski RT, Forrester SR, et al. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma J Clin Endocrinol Metab 89:5694–5699, 2004.PubMedCrossRefGoogle Scholar
  12. 12.
    Muller U, Troidl C, Niemann S. SDHC mutations in hereditary paraganglioma/pheochromocytoma. Fam Canar 4:9–12, 2005.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2006

Authors and Affiliations

  • Marion Jech
    • 4
  • I. Alvarado-Cabrero
    • 1
  • J. Albores-Saavedra
    • 2
  • P. L. M. Dahia
    • 4
  • A. S. Tischler
    • 3
  1. 1.Department of Pathology, Oncology HospitalIMSSMexico
  2. 2.Department of PathologyLSU Health Sciences CenterShreveport
  3. 3.Department of PathologyTufts-New England Medical CenterBoston
  4. 4.Department of Medicine and Cellular & Structural BiologyUniversity of Texas Health Science CenterSan Antonio

Personalised recommendations